コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 r hematopoietic stem cell transplantation in primary immunodeficiency disease.
2 is and management of patients with suspected primary immunodeficiency diseases.
3 nostic evaluation of patients with suspected primary immunodeficiency diseases.
4 t studies to determine optimal therapies for primary immunodeficiency diseases.
5 that study the treatment of rare and severe primary immunodeficiency diseases.
6 pplications for the domain of immunology and primary immunodeficiency diseases.
7 ws for emergence of many autosomal recessive primary immunodeficiency diseases.
8 he cornerstone of treatment in patients with primary immunodeficiency diseases affecting the humoral
9 We have therefore identified the cause for a primary immunodeficiency disease and determined the mech
10 s progress in the study of rare variants and primary immunodeficiency diseases arising from whole-exo
11 globulin is used as a replacement therapy in primary immunodeficiency diseases as well as an immunomo
12 Activated PI3K Delta Syndrome (APDS) is a primary immunodeficiency disease caused by activating mu
13 is (WHIM) syndrome is an ultra-rare combined primary immunodeficiency disease caused by heterozygous
15 f B-lineage acute lymphoblastic leukemia and primary immunodeficiency diseases characterized by agamm
16 ciency disorders (CVID) represent a group of primary immunodeficiency diseases characterized by hypog
17 ommon variable immune deficiency (CVID) is a primary immunodeficiency disease, characterized by hypog
18 ican Academy of Allergy, Asthma & Immunology Primary Immunodeficiency Diseases Committee established
19 y in Japan is reaching out regionally to the primary immunodeficiency disease community and internati
24 Hem-1 have recently been found to result in primary immunodeficiency disease (PID) in humans, charac
25 and malignancies-are known to exist in many primary immunodeficiency diseases (PID) and to participa
28 pecific incidence of cancer in subjects with primary immunodeficiency diseases (PIDD) enrolled in the
31 ideration of many patients suspected to have primary immunodeficiency diseases (PIDDs) is the applica
36 been reported occasionally in patients with primary immunodeficiency diseases (PIDs) since the early
41 here is urgent need for the establishment of primary immunodeficiency disease registries, stem cell t
44 n infantile onset of the autosomal recessive primary immunodeficiency disease veno-occlusive disease
46 side other symptoms in patients with various primary immunodeficiency diseases with diverse genetic d